Oxymorphone Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 64896-698

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 64896-698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Oxymorphone Extended Release Tablets Speciality 1)

Chemical structure of oxymorphone hydrochloride shown as a molecular diagram with labeled functional groups including hydroxyl, methyl, ketone, and nitrogen atoms, along with the hydrochloride (HCl) salt.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 10)

Label for Oxymorphone Hydrochloride Extended-Release Tablets USP 40 mg by Amneal Pharmaceuticals LLC. The label indicates twice-a-day dosing every 12 hours and includes a medication guide instruction for pharmacists. It also shows a package count of 100 tablets, relevant storage and safety information, and a QR code linking to the medication guide.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 2)

A line graph comparing the percentage of patients improved in pain for Oxymorphone extended-release (ER) versus placebo. The x-axis shows the percent of reduction or improvement in pain, ranging from 0 to 100%, and the y-axis shows the percentage of patients improved, ranging from 0 to 100%. The graph depicts a higher percentage of patients improving with Oxymorphone ER across most levels of pain reduction compared to placebo.*

FDA Label Image

10 (Oxymorphone Extended Release Tablets Speciality 3)

A line graph comparing the percentage of patients improved at different levels of reduction or improvement in pain between Oxymorphone ER and placebo. The x-axis shows percent reduction/improvement in pain, while the y-axis shows the percentage of patients improved. Two lines represent Oxymorphone ER and placebo over the range of pain improvement.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 4)

Label for Oxymorphone Hydrochloride Extended-Release Tablets, USP 5 mg by Amneal Pharmaceuticals LLC. The label indicates a twice-a-day (every 12 hours) dosage with 100 tablets per container for Rx only. It includes a medication guide notice for the pharmacist, usage instructions, and storage warnings. A QR code and barcode are present for additional information and scanning.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 5)

Label for Oxymorphone Hydrochloride Extended-Release Tablets, USP 7.5 mg by Amneal Pharmaceuticals LLC. The tablets are film-coated and intended for oral use, provided in a container of 100 tablets with a twice-a-day dosing recommendation. The label includes usage instructions, safety warnings, and a QR code linking to the medication guide.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 6)

Label for Oxymorphone Hydrochloride Extended-Release Tablets USP 10 mg by Amneal Pharmaceuticals LLC. The label specifies a twice-a-day dosing schedule every 12 hours. The package contains 100 film-coated, extended-release oral tablets. It includes medication guide instructions, handling and storage information, and warnings that the tablets must be swallowed whole and kept out of reach of children. The label features the NDC number 64896-697-01 and includes a QR code for accessing the medication guide online.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 7)

Label for Oxymorphone Hydrochloride Extended-Release Tablets, USP 15 mg by Amneal Pharmaceuticals LLC. The label indicates this is a prescription medication with a 15 mg strength, extended-release film-coated tablet form. It includes directions for twice-a-day dosing every 12 hours and packaging details for 100 tablets. Additional safety and storage instructions, a QR code, and lot/expiration date area are visible.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 8)

Label for Oxymorphone Hydrochloride Extended-Release Tablets, USP 20 mg by Amneal Pharmaceuticals LLC. The label states a twice-a-day dosing schedule and that it is prescription-only. The package contains 100 tablets, and instructions highlight dispensing a Medication Guide to each patient. The label includes a QR code and barcode with additional product and safety information.*

FDA Label Image

1 (Oxymorphone Extended Release Tablets Speciality 9)

Label for Oxymorphone Hydrochloride Extended-Release Tablets, USP 30 mg by Amneal Pharmaceuticals LLC. The label indicates the tablets are film coated and for oral use, with a package count of 100 tablets. It instructs to take the tablets whole, not crushed or chewed, and highlights a twice-a-day dosing every 12 hours. Includes a QR code linking to the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.